REJUVEL BIO-SCIENCES, INC. — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2014)

$94.1K

Net Income/Loss (FY2014)

-$352.9K

Total Assets (FY2014)

$104.7K

Total Equity (FY2014)

-$833.4K

Cash Flows from Operating Activities (FY2014)

-$493.8K

Source: REJUVEL BIO-SCIENCES, INC. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.